Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin in SLEDD for ICU patients
NCT03614741Phase 4Recruiting
- Sponsor
- Tampere University Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tinzaparin in venous thromboembolism (VTE), sponsored by Tampere University Hospital. Started Dec 2018; status: recruiting.
02
Drugs
tinzaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03614741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614741.